Tuesday, November 25, 2008

Non-Toxic MDR Cancer Therapy!

The future of cancer treatment and the chances of survival look more promising than ever. As a result of confidential communications involving a researcher from one of Americas largest pharmaceutical companies, the anti-cancerous, anti-tumorous (CAM) Complimentary or Alternative Medicine, is finally coming to public attention. Here you will learn about an astounding opportunity to kill cancer using (CAM) which is made by a recipe of natural bioactive compounds, phytochemicals, novel alkaloids and acetogenins that are anti-cancerous, anti-tumorous, and non-toxic, anti-viral, anti-parasitic.

Defibrillators May Fail - Says Medical Devices Regulator

Defibrillators May Fail - Says Medical Devices Regulator
First aiders and users of Medtronic Physio-Control LIFEPAK CR Plus automatic external defibrillators (AED) are being told today to test their device by the Medicines and Healthcare products Regulatory Agency (MHRA) following advice from the manufacturer over concerns that the defibrillator could fail to turn on and work due to a faulty internal cable.

The Decline In Cardiovascular Mortality Credited To Several Factors
The past two to three decades have been associated with a decline in deaths from both coronary artery disease and carotid artery-based stroke. Certain countries, notably England, The Netherlands, Finland, New Zealand, and Canada have had a similar experience. In the United States, age-adjusted death rate for coronary heart disease (CAD) fell from 542.9 to 266.8 deaths per 100,000 population in men, and from 263.3 to 134.4 deaths among women from, 1980 through 2000. Allan D.

Relationship Between Annual Open Case Load And Operative Mortality: Implications For Patient Choice And System Reconfiguration
A central question in the provision of complex surgical interventions is the configuration of elective and emergency surgical centers, namely, should complex surgery be regionalized in units that exceed a certain threshold of elective and emergency cases. Matthew M. Thompson, M.D., Professor at the University of London and Professor of Vascular Surgery at St.

A Simple Blood Test Proving To Be An Effective Predictor Of Cardiac Risk In Vascular Surgery Patients
Don Poldermans, M.D., Professor and Internist at the Erasmus Medical Center, announced exciting results that the N-terminal pro-Btype natriuretic peptide (Serum NT-proBNP) is an independent prognostic marker for postoperative cardiac events and long-term mortality in patients undergoing different types of vascular surgery, and might be used for preoperative cardiac risk stratification.

New Developments In Anti-Platelet Agents Revealed At The VEITH Symposium
The use of anti-platelet medications for prevention of cardiovascular events is in a state of evolution. Samuel R. Money, M.D., M.B.A., Professor of Surgery and Chair, Division of Vascular Surgery at the Mayo Clinic in Scottsdale, Arizona, stated that although strides have been made in understanding of platelet physiology, further investigation and understanding of platelet adhesion, activation, and aggregation are critical to the successful use of these medications.

The Case For Cryoplasty For Limb Salvage In Patients With Critical Ischemia
Thomas O. McNamara, M.D., Professor of Radiological Sciences at the UCLA Medical Center, Member of the Section of Vascular Interventional Radiology, and a full-time faculty member of the UCLA School of Medicine, reported at the VEITHsymposium that cryoplasty therapy is a safe and effective method of treating advanced below the knee lesions with marked critical limb ischemia (CLI), yielding excellent acute outcomes and a high rate of limb salvage at both 6 and 12 months.

Carotid Endarterectomy Better Than Stenting For Artery Stenosis
Narrowing (stenosis) of the carotid artery, which supplies blood to the brain, may lead to a stroke or transient ischemic attack often called a "mini-stroke" or TIA. Several large, multi center randomized trials in the 1990s found that carotid endarterectomy (CEA) surgery is an effective procedure for preventing stroke when the degree of stenosis is more than 60 percent; it remains the procedure of choice for patients with severe carotid artery stenosis.

Numerical Models Better Than Animal Models For Design, Testing Of Endovascular Grafts And Should Make Animal Models Obsolete
Until as recently as a couple of years ago, mathematical modeling of human aortas was limited to either modeling the stream of flow through the geometry of an aneurysm assuming rigid walls or calculating the mechanical loads on its walls. Today, Fluid-Structure Interaction (FSI) methods permit studying both processes (fluid flow and wall motion) simultaneously. Ramon Berguer, M.D., Ph.D.